Jack Hidary

CEO, SandboxAQ
· tracked since Jun 2026
Calls
1
Win Rate
100.0%
return
+13.7%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 1
Best Calls
XBI Long +13.7%
Worst Calls
No live losers yet
Most Mentioned
XBI ×1
Recent Calls
XBI Long 2 months ago
Win Rate 100% Long 1 Short 0
Win Rate
7d 100%
30d 100%
90d —
Average Return +13.7% Long Return +13.7% Short Return -
Average Return
7d +6.9%
30d +2.9%
90d —
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
XBI SPDR S&P... SPDR S&P Biotech ETF
Long
Jun 23
$147.98
+13.7%
AI accelerates drug discovery, bullish for biotech.
AI-driven physics-based models (Nvidia BioNeMo + SandboxAQ AQ state) enable virtual screening of GPCR-targeting drug candidates, cutting discovery time from years/decades to weeks/months and improving success rates. This breakthrough transforms drug discovery, making biotech and healthcare a massive addressable sector with strong tailwinds as drug companies, biotech firms, and researchers adopt these tools.
Thematic ETFs
YOUTUBE
Showing 1 of 1 calls · sorted by mentions

Jack Hidary has 1 trade ideas tracked on Buzzberg across 1 tickers since June 2026. Most covered: XBI.